Your blog category
Gland Pharma’s Q2 FY26 results have been reviewed by Motilal Oswal, with the brokerage firm hiking its target price post inline revenue. Find out more about the review and what it means for investors.
Get the latest stock recommendations from top analysts, including Tata Consumer, Lupin, Torrent Power, Home First Finance, and BSE. Learn how to make informed investment decisions with our in-depth analysis.
Tata Consumer Products Ltd. reports strong Q2 FY26 results, with operating topline exceeding expectations. Yes Securities maintains ‘Buy’ rating and hikes target price.
The Indian stock market, including BSE and NSE, will remain closed on November 5, 2025, due to Guru Nanak Jayanti. Find out the trading schedule and holidays for the year.
Fitch Ratings has upgraded the outlook on Adani Ports and Special Economic Zone Ltd., Adani Green Energy Ltd., and Adani Electricity Mumbai Ltd. Understand the implications for Indian investors.
The Indian food delivery market is witnessing an intense competition between Eternal Ltd. and Swiggy Ltd., with both players expanding their services to gain market share. Here’s an in-depth analysis of the current scenario and what it means for investors.
Bharti Airtel’s Q2 results have exceeded expectations, with strong growth across India Homes and Africa operations, and a significant increase in net profit. Jefferies has raised its target price on the stock to Rs 2,635, maintaining a ‘Buy’ rating.
Bitcoin has plunged 15% from its record high, affecting the broader crypto market. We analyze the reasons behind this downturn and its implications for Indian investors and traders.
Suzlon Energy Ltd.’s consolidated net profit surged six-fold in the second quarter of the current financial year, driven by a tax write-back of Rs 718 crore.
Ajanta Pharma’s Q2 FY26 results exceeded estimates, driven by strong growth in the US and India. Is this a buying opportunity for investors?